Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited（TLX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
tlx · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Buy
5 位分析师
共识
评级分布
12 个月目标价
High
$17.00
Consensus
$17.00
+81.2% upside
Low
$17.00
Median: $17 · Last Close: $9.38
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.97 | ↓ 4.40% |
1-day model range: $8.92–$9.02. Peak: $9.02 (-4.40%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $6 | -40.0% |
| 2028 | $4 | -54.4% |
| 2029 | $4 | -61.0% |
| 2030 | $3 | -64.3% |
| 2031 | — | -66.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TLX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-13 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-07 | Wedbush | Maintains | Outperform→Outperform |
| 2026-02-24 | Citigroup | Maintains | Buy→Buy |
| 2026-01-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-23 | UBS | Maintains | Buy→Buy |
| 2025-09-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-28 | Wedbush | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Telix Pharmaceuticals Limited (TLX) stock. Of the recent 13 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover TLX.
分析师推荐趋势
TLX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1.4B
↓ 26.9% YoY
Revenue Next Year
$1.7B
↑ 17.4% YoY
EPS This Year
$0.06
EPS Next Year
$0.15
↑ 160.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast TLX EPS of $0.06 for the current fiscal year, based on estimates from 6 analysts. The TLX revenue forecast is $1.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
TLX 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。TLX 的共识目标价为 $17.00（+81.2% 上行空间），分析师共识为 Buy。
TLX 的短期预测（明日）为 $8.97（-4.40%）。 TLX 对 2027 年的股价预测均值为 $6。 TLX 对 2030 年的预测区间为 $3–$4。
Telix Pharmaceuticals Limited 在 NASDAQ 上市，代码 TLX。TLX 在 2027 年的整体展望偏积极，在覆盖分析师中约 80% 对应 Buy 共识。
常见问题
TLX 预测 · 8 个问题根据 5 位华尔街分析师，TLX 的 12 个月平均目标价为 $17.00，最高 $17.00、最低 $17.00。若有图表，中位目标价可在上方查看。相对当前价 $9.38，隐含约 +81.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.